Figure 2. Kaplan‐Meier curves for the cumulative incidence of the primary outcome based on the high‐density lipoprotein cholesterol (HDL‐C) categories.

A, Regardless of inflammation. B, In the absence of inflammation. C, In the presence of inflammation. The cumulative incidence of extended major adverse cardiovascular events was notably lower in patients without inflammation and with HDL‐C level ≥60 mg/dL, whereas this pattern disappeared in those with inflammation. Statistical analysis was performed using the log‐rank test.